Pub. Date : 2009 Dec 1
PMID : 19923318
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Initial clinical studies have suggested that EGFR inhibitors such as gefitinib may delay the development of resistance to endocrine therapy in patients with breast cancer when given concurrently with tamoxifen or an aromatase inhibitor. | Tamoxifen | epidermal growth factor receptor | Homo sapiens |